REFERENCES
- Foley KM. Palliat Med. 2011;25(5):398–401.
- Institute of Medicine. Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education and Research. Washington, DC, The National Academies Press, 2011. Available at: www.iom.edu. Accessed July 2014.
- Green CR, Hart-Johnson T, et al. Cancer 2011;117(9): 1994–2003.
- Lawlor P. Multidimensional assessment: pain and palliative care. In Bruera E, Portenoy R., editors, Cancer Pain: Assessment and Management. Cambridge, Cambridge University Press, 2003.
- Mystakidou K, Tsilika E, et al. Cancer Nurs. 2006;29(5):400–5.
- International Pain Summit of the International Association for the Study of Pain. J Pain Palliat Care Pharmacother. 2011;25(1):29–31.
- Caraceni A, Hanks G, et al. Lancet Oncol. 2012;13(2):e58–68.
- Provenzano DA, Viscusi ER. Rethinking the role of opioids in the outpatient management of chronic nonmalignant pain. Curr Med Res Opin. 2014:1–12. [Epub ahead of print].
- Pert CB, Snyder SH. Science 1973;179(4077):1011–14.
- Simon EJ, Hiller JM, et al. Proc Natl Acad Sci USA. 1973;70(7):1947–9.
- Terenius L. Acta Pharmacol Toxicol. 1973;33(5): 377–84.
- Martin WR, Eades CG, et al. J Pharmacol Exper Therapeut. 1976;197(3):517–32.
- Davis MP, Pasternak GW. Opioid receptors and opioid pharmacodynamics. In Davis M, Glare P, et al., editors, Opioids in Cancer Pain. Oxford, Oxford University Press, 2005.
- Manara L, Bianchetti A. Ann Rev Pharmacol Toxicol. 1985;25:249–73.
- Camilleri M. Amer J Gastroenterol. 2011;106(5):835–42.
- Rachinger-Adam B, Conzen P, et al. Curr Opin Anaesthesiol. 2011;24(4):408–13.
- Holzer P. Therapy 2008;5(4):531–43.
- Bell TJ, Panchal SJ, et al. Pain Med. 2009;10(1):35–42.
- Kalso E, Edwards JE, et al. Pain 2004;112(3):372–80.
- NICE. Opioids in Palliative Care: Safe and Effective Prescribing of Strong Opioids for Pain in Palliative Care of Adults. CG140. London, NICE, 2012. Available at: www. nice.org.uk/guidance/CG140. Accessed July 2014.
- Pappagallo M. Am J Surg. 2001;182(5A Suppl): 11S–8S.
- Raimer K, Hopp M, et al. Pharmacology 2009;83(1):10–7.
- Candy B, Jones L, et al. Cochrane Database of Systematic Reviews, 2011, Issue 1. Art No: CD003448. DOI:10.1002/14651858.CD003448.pub3.
- Davis MP. Oxycodone. In Davis M, Glare P, et al. editors, Opioids in Cancer Pain. Oxford, Oxford University Press, 2005.
- Twycross R, Wilcock A. Opioid dose conversion ratios. In Palliative Care Formulary, 4th ed.. Nottingham, Palliativedrugs.com Ltd., 2011.
- Oxycodone Hydrochloride 5 mg/5 ml Oral Solution SPC. Wockhardt UK Ltd. Available at: www.medicines.org.uk. Accessed July 2014.
- Mercadante S, Giarratano A. Expert Opin Invest Drugs. 2013;22(1):161–6.
- Targin 5 mg/2.5 mg, 10 mg/5 mg, 20 mg/10 mg and 40 mg/20 mg prolonged-release tablets SPC. 2013. Available at: www.medicines.ie. Accessed September 2014.
- Smith K, Hopp M, et al. Clin Therapeut. 2008;30(11):2051–68.
- Hanna M. Palliat Med. 2011;25(5):604–5.
- Vondrackova D, Leyendecker P, et al. J Pain. 2008;9(12): 1144–54.
- Simpson K, Leyendecker P, et al. Curr Med Res Opin. 2008;24(12):3503–12.
- Meissner W, Leyendecker P, et al. Eur J Pain. 2009;13(1):56–64.
- Ahmedzai SH, Nauck F, et al. Palliat Med. 2012;26(1):50–60.